Inventor · disambiguated record
Kavita Praveen
Also filed as: PRAVEEN KAVITA
9 granted patents·10 pending applications·2 citations·filing 2018–2025
77Inventor score
Files withREGENERON PHARMA19
Top patents by PatentIndex Score
19 records- 0184US11820982B2Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitorsREGENERON PHARMA·Filed 2021·Granted Nov 21, 2023·1 cites·7 claims
- 0284US11674177B2Kelch domain containing 7B (KLHDC7B) variants and uses thereofREGENERON PHARMA·Filed 2021·Granted Jun 13, 2023·1 cites·10 claims
- 0381US12258627B2Kelch domain containing 7B (KLHDC7B) variants and uses thereofREGENERON PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0474US2024148774A1Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0573US2024102013A1Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0672US2025250631A1Kelch Domain Containing 7B (KLHDC7B) Variants And Uses ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0770US11865134B2Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 0866US11098363B2Cornulin (CRNN) variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Aug 24, 2021·0 cites·14 claims
- 0963US11512309B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2021·Granted Nov 29, 2022·0 cites·13 claims
- 1063US2023279400A1Methods Of Treating Headaches And Migraines With Sodium Voltage-Gated Channel Alpha Subunit 11 (SCN11A) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1163US2022064735A1Synaptojanin 2 (SYNJ2) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1262US11767526B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Sep 26, 2023·0 cites·11 claims
- 1362US2022017964A1Cornulin (CRNN) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1459US11825819B2Crnn loss of function rodent modelREGENERON PHARMA·Filed 2020·Granted Nov 28, 2023·0 cites·13 claims
- 1557US2020370119A1Synaptojanin 2 (SYNJ2) Variants And Uses ThereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1656US11845989B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Dec 19, 2023·0 cites·4 claims
- 1753US2021300976A1Fascin-2 (FSCN2) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1851US2021371930A1Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1950US2022089664A1Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kavita Praveen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →